This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shelton, M. E. Articles by Bergmann, S. R. Search for Related Content PubMed PubMed Citation Articles by Shelton, M. E. Articles by Bergmann, S. R.

Circulation, Vol 82, 990-997, Copyright © 1990 by American Heart Association

ARTICLES

Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography

ME Shelton, MA Green, CJ Mathias, MJ Welch and SR Bergmann
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

We recently demonstrated in isolated, perfused hearts that radiolabeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II) (Cu-PTSM) is well extracted throughout a range of conditions including ischemia, hypoxia, and hyperemia. Once extracted, binding of radioactivity by the isolated heart was essentially irreversible, giving this tracer microspherelike qualities. Because Cu-PTSM can be readily prepared with the generator-produced positron-emitting copper 62 and other gamma- or positron-emitting copper radionuclides, we evaluated its usefulness for measuring regional myocardial and renal blood flow in vivo in intact dogs at rest, after ischemia, or after coronary hyperemia was induced by intravenous administration of dipyridamole. After intravenous administration of radiolabeled Cu-PTSM, the tracer cleared rapidly from the blood. Myocardial uptake of single photon-emitting 67Cu-labeled Cu- PTSM was measured directly in myocardial samples 15 minutes after tracer administration, and it increased proportionally with blood flow throughout the flow range (estimated concomitantly with radiolabeled microspheres) of 0.0-6.0 ml/g/min (n = 340 samples from 17 dogs, r = 0.99, Ycopper radioactivity = 85Xmicrosphere flow -7 chi 2 + 17). Renal uptake of radiolabeled Cu-PTSM was also proportional to blood flow. Positron emission tomography was performed in four intact dogs after intravenous administration of 64Cu-labeled Cu-PTSM (19% positron decay, t1/2 = 12.8 hours). High-quality images of heart and kidney were obtained. Accordingly, radiolabeled Cu-PTSM should be a useful, generator-produced tracer for estimating regional myocardial and renal blood flow with positron emission tomography.

This article has been cited by other articles:

				G. D. Hutchins What Is the Best Approach to Quantify Myocardial Blood Flow with PET? J. Nucl. Med., August 1, 2001; 42(8): 1183 - 1184. [Full Text] [PDF]

				R. C. Marshall, P. Powers-Risius, B. W. Reutter, S. E. Taylor, H. F. VanBrocklin, R. H. Huesman, and T. F. Budinger Kinetic Analysis of 125I-Iodorotenone as a Deposited Myocardial Flow Tracer: Comparison with 99mTc-Sestamibi J. Nucl. Med., February 1, 2001; 42(2): 272 - 281. [Abstract] [Full Text]